Analysts think DXCM stock price could increase by 55%
Apr 03, 2025, 11:25 AM
19.71%
What does DXCM do
DexCom, headquartered in San Diego, develops glucose monitoring systems for diabetes management, employing 9,600 people since its IPO in 2005. Its products include the Dexcom G6 and G7 continuous glucose monitoring systems.
27 analysts think DXCM stock price will increase by 54.93%. The current median analyst target is $105.57 compared to a current stock price of $68.14. The lowest analysts target is $82.82 and the highest analyst target is $126.00.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
